Fortress Biotech, Inc.FBIONASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-74.00%
↓ 130% below average
Average (39q)
-32.16%
Historical baseline
Range
High:204.17%
Low:-951.16%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -74.00% |
| Q2 2025 | 204.17% |
| Q1 2025 | -29.73% |
| Q4 2024 | 51.32% |
| Q3 2024 | -4.11% |
| Q2 2024 | 29.13% |
| Q1 2024 | 13.45% |
| Q4 2023 | -26.60% |
| Q3 2023 | 74.25% |
| Q2 2023 | -5.19% |
| Q1 2023 | 55.51% |
| Q4 2022 | -89.78% |
| Q3 2022 | -5.38% |
| Q2 2022 | -44.44% |
| Q1 2022 | 52.30% |
| Q4 2021 | -47.78% |
| Q3 2021 | -489.23% |
| Q2 2021 | 60.37% |
| Q1 2021 | -64.00% |
| Q4 2020 | 67.32% |
| Q3 2020 | -5.15% |
| Q2 2020 | 0.34% |
| Q1 2020 | 24.94% |
| Q4 2019 | -15.43% |
| Q3 2019 | 7.92% |
| Q2 2019 | -951.16% |
| Q1 2019 | 104.97% |
| Q4 2018 | -55.48% |
| Q3 2018 | 25.44% |
| Q2 2018 | -0.81% |
| Q1 2018 | -144.55% |
| Q4 2017 | 69.67% |
| Q3 2017 | -55.61% |
| Q2 2017 | -44.27% |
| Q1 2017 | 31.64% |
| Q4 2016 | -34.23% |
| Q3 2016 | -3.41% |
| Q2 2016 | -1.52% |
| Q1 2016 | -1.09% |
| Q4 2015 | 33.86% |